Herbert K. Lyerly
12Patents
3h-index
13Co-inventors
49Inventor score
Filing activity: Jan 21, 2013 → Nov 19, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10562864B2 | Chemical modulators of immune checkpoints and therapeutic use | Human Necessities | 11 | Active |
| US10189797B2 | Chemical modulators of immune checkpoints and therapeutic use | Human Necessities | 11 | Active |
| US9956276B2 | Vaccines against antigens involved in therapy resistance and methods of using same | Chemistry; Metallurgy | 7 | Active |
| US10487143B2 | Vaccines against HER3 antigens and methods of using the same | Chemistry; Metallurgy | 1 | Active |
| US12083172B2 | Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same | Chemistry; Metallurgy | 0 | Active |
| US11224665B2 | Mitochondrial antiviral signaling (MAVS) protein compositions and methods of using the same | Chemistry; Metallurgy | 0 | Active |
| US11235043B2 | Vaccines against antigens involved in therapy resistance and methods of using same | Chemistry; Metallurgy | 0 | Active |
| US11253580B2 | Cancer vaccines and methods of delivery | Human Necessities | 0 | Active |
| US10842857B2 | Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same | Chemistry; Metallurgy | 0 | Active |
| US10842855B2 | Vaccines against an oncogenic isoform of ESR1 and methods of using the same | Chemistry; Metallurgy | 0 | Active |
| US11987579B2 | Niclosamide analogues and therapeutic use thereof | Chemistry; Metallurgy | 0 | Active |
| US10905665B2 | Chemical modulators of signaling pathways and therapeutic use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.